Identification and characterization of loop7 motif and its role in regulating biological function of human APOBEC3G

Congjie Zhai1, Ling Ma1, Zhixin Zhang1

  • 1Institute of Medicinal Biotechnology, Chinese Academy of Medical Science, Beijing 100050, China.

Acta Pharmaceutica Sinica. B
|September 20, 2017
PubMed

Insights

Human APOBEC3G (hA3G) inhibits HIV-1, but the viral infectivity factor (Vif) targets hA3G for degradation. This study reveals loop7 controls hA3G dimerization and Vif interaction, offering a strategy to block Vif-mediated degradation.

Area of Science:

  • Virology
  • Molecular Biology
  • Biochemistry

Background:

  • Human APOBEC3G (hA3G) is a key antiviral factor inhibiting HIV-1 replication.
  • The HIV-1 viral infectivity factor (Vif) protein antagonizes hA3G by promoting its proteasomal degradation.

Purpose of the Study:

  • To investigate the structural and functional roles of the hA3G loop7 motif in hA3G dimerization and Vif interaction.
  • To elucidate the mechanism by which Vif targets hA3G for degradation.
  • To explore therapeutic strategies targeting the Vif-hA3G interaction.

Main Methods:

  • Molecular modeling of hA3G dimer and hA3G-Vif complex.
  • Biochemical analyses to assess protein interactions and degradation.
  • Mutagenesis studies to investigate the role of loop7 residues.

Main Results:

  • The loop7 motif of hA3G is crucial for both hA3G dimerization and Vif binding.
  • Vif binding sterically hinders hA3G dimerization, suggesting monomeric hA3G is the substrate for Vif-mediated degradation.
  • The loop7 motif regulates hA3G's biological functions, including dimerization, Vif interaction, degradation, and subcellular localization.

Conclusions:

  • The hA3G loop7 motif acts as a multifunctional interface regulating hA3G's antiviral activity and Vif interaction.
  • Targeting the loop7 region offers a potential strategy to inhibit Vif-mediated hA3G degradation and enhance antiviral defense.